Table 3.

Effects of Kangshuanling sublingual tablets on CD54 in UC patients (mean ± SD, %)

Group	Blood CD54	Tissue CD54	Blood Pgp-170	Tissue Pgp-170
UC patients
Pre-treatment	26.9 ± 6.9b	51.1 ± 6.2b	18.9 ± 3.9b	16.5 ± 3.2b
Post-treatment	14.4 ± 5.1a,d	23.1 ± 4.1a,d	10.4 ± 2.7a,c	10.2 ± 2.3a,c
Normal controls	6.2 ± 3.7	8.8 ± 3.2	6.2 ± 2.2	6.8 ± 3.1

^aP < 0.05,

^bP < 0.01 vs normal controls;

^cP < 0.05 vs pre-treatment,

^dP < 0.01 vs pre-treatment.